Core Viewpoint - A malicious rumor regarding the new tea drink brand "霸王茶姬" (Bawang Chaji) claiming its caffeine content is akin to "quasi-drugs" has led to legal action against the individual responsible for spreading the misinformation, significantly impacting the brand's reputation and consumer trust [1][6]. Group 1: Incident Overview - The incident originated on December 26, 2025, when an individual named Ren spread false claims on social media about Bawang Chaji's high-caffeine drinks being dangerous, which caused widespread consumer concern about the safety of the products [1]. - Following the spread of the rumor, Bawang Chaji issued a comprehensive response on Weibo, clarifying that caffeine is a naturally occurring substance in tea and not an additive, and provided data to compare caffeine levels in their drinks to those in coffee [1][6]. Group 2: Consumer Reactions - Discussions about insomnia and palpitations after consuming Bawang Chaji products had already begun in 2024, with consumers reporting heightened alertness and sleep disturbances after drinking specific products [2]. - Bawang Chaji responded to these concerns by explaining that the caffeine content in their "万里木兰" (Wanli Mulian) drink is comparable to that of a latte, which may affect caffeine-sensitive individuals more noticeably [2]. Group 3: Product Information - The caffeine content in Bawang Chaji's drinks is approximately 31.8 mg per 100 ml, which is similar to that of a latte and significantly lower than that of an Americano [5]. - The company emphasizes the use of original tea leaves and natural ingredients in their products, allowing consumers to check caffeine levels through their app before purchase [6]. Group 4: Company Performance - Bawang Chaji reported a growth trend in its business, with its Q3 2025 financial results showing a total of 7,338 global stores, a GMV of 7.93 billion yuan, net revenue of 3.208 billion yuan, and an adjusted net profit of 503 million yuan, achieving profitability for 11 consecutive quarters [6].